High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis

Leuschner, U.; Lindenthal, Birgit; Herrmann, Günter; C. Arnold, Joachim; Rössle, Martin; Cordes, Hans-Jörg; Zeuzem, Stefan; Hein, J; Berg, Thomas

doi:10.1002/hep.23727

Public

High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis

Published in Hepatology • Apr 23, 2010

Authors:

U. Leuschner

Birgit Lindenthal

Günter Herrmann

Abstract

UNLABELLED: In uncontrolled clinical studies, ursodeoxycholic acid (UDCA) had a beneficial effect on nonalcoholic steatohepatitis (NASH). However, a large controlled trial using UDCA (13-15 mg/kg/day) was unable to confirm these results. Accordingly, a randomized, placebo-controlled study was initia...

Subject

Ursodeoxycholic acid

Nonalcoholic steatohepatitis

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!